Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice-Reference-Cited by-同舟云学术

Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice

Published:2017-03-31 Issue:5 Volume:65 Page:1628-1644
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hou Guojun¹²,Chen Lei¹³,Liu Gang⁴,Li Liang¹³,Yang Yuan²,Yan He-Xin¹³,Zhang Hui-Lu¹,Tang Jing¹,Yang Ying Cheng¹,Lin Ximeng¹,Chen Xin¹,Luo Gui juan¹,Zhu Yanjing¹,Tang Shanhua¹³,Zhang Jin²,Liu Hui²,Gu Qingyang⁵,Zhao Ling-Hao²,Li Yixue⁶,Liu Lei⁴,Zhou Weiping²³,Wang Hongyang¹³⁷

Affiliation:

1. The International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital; Second Military Medical University; Shanghai China

2. The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital; Second Military Medical University; Shanghai China

3. National Center for Liver Cancer; Shanghai China

4. Shanghai Public Health Clinical Center and Institutes of Biomedical Sciences; Fudan University; Shanghai China

5. Oncology Business Unit; WuXi AppTec Co., Ltd.; Shanghai China

6. CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences; Chinese Academy Sciences; Shanghai China

7. State Key Laboratory for Oncogenes and Related Genes, Cancer Institute of RenJi Hospital; Shanghai JiaoTong University; Shanghai China

Funder

National Key Basic Research Program of China

State Key Infection Disease Project of China

Science Fund for Creative Research Groups

Shanghai New Excellent youth plan

National High Technology Research and Development Program of China